A surgical team at St. Elizabeth Edgewood (Ky.) Hospital recently performed the first implantation of a Bluetooth-connected cardiac defibrillator in the U.S.

The device, called the Abbott Gallant, is a biventricular implantable cardiac defibrillator that earned FDA approval in July and is the first to wirelessly pair with a smartphone app for patients. 

Mohamad Sinno, MD, a cardiac electrophysiology specialist at St. Elizabeth Edgewood, led the procedure. 

Learn more here.

More articles on cardiology:
Potential COVID-19 treatment could increase cardiac event risk if taken with certain drugs 
NewYork-Presbyterian Brooklyn Methodist Hospital names new cardiology chief
Journal of Invasive Cardiology to go 100% digital

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.